Impact of onset-to-reperfusion time on stroke mortality: A collaborative pooled analysis

Circulation

Volumn 127, Issue 19, 2013, Pages 1980-1985

  Mazighi, Mikael ^a   Chaudhry, Saqib A ^b   Ribo, Marc ^c   Khatri, Pooja ^d   Skoloudik, David ^e   Mokin, Maxim ^f   Labreuche, Julien ^a   Meseguer, Elena ^a   Yeatts, Sharon D ^g   Siddiqui, Adnan H ^f   Broderick, Joseph ^d   Molina, Carlos A ^c   Qureshi, Adnan I ^b   Amarenco, Pierre ^a  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITY OF MINNESOTA   (United States)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^f UNIVERSITY AT BUFFALO   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

meta analysis; stroke; stroke reperfusion injury

Indexed keywords

ARTICLE; BRAIN HEMORRHAGE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; HEART MUSCLE REPERFUSION; HUMAN; HYPERTENSION; INTERNAL CAROTID ARTERY OCCLUSION; META ANALYSIS; MIDDLE CEREBRAL ARTERY OCCLUSION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVASCULARIZATION; SMOKING;

META-ANALYSIS; STROKE; STROKE REPERFUSION INJURY;

COOPERATIVE BEHAVIOR; ENDOVASCULAR PROCEDURES; HUMANS; PILOT PROJECTS; PROSPECTIVE STUDIES; REPERFUSION; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84877887447     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.000311     Document Type: Article

References (22)

1. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007;38:967-973.
2. Mazighi M, Serfaty JM, Labreuche J, Laissy JP, Meseguer E, Lavallée PC, Cabrejo L, Slaoui T, Guidoux C, Lapergue B, Klein IF, Olivot JM, Abboud H, Simon O, Niclot P, Nife C, Touboul PJ, Raphaeli G, Gohin C, Claeys ES, Amarenco P; RECANALISE Investigators. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confrmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol. 2009;8:802-809.
3. Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick J P, Tomsick TA; IMS I and II Investigators. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology. 2009;73:1066-1072.
4. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O. Recombinant tissue plas-minogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78-86.
5. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G; ECASS, ATLANTIS, NINDS, and EPITHET rt-PA Study Group. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695-1703.
6. Molina CA, Alexandrov AV, Demchuk AM, Saqqur M, Uchino K, Alvarez-Sabín J; CLOTBUST Investigators. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke. 2004;35:151-156.
7. IMS Study Investigators. Combined intravenous and intra-arterial re-canalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke.2004;35:904-911.
8. IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke. 2007;38:2127-2135.
9. Meseguer E, Mazighi M, Lapergue B, Labreuche J, Sirimarco G, Gonzalez-Valcarcel J, Lavallée PC, Cabrejo L, Guidoux C, Klein IF, Olivot JM, Rouchaud A, Desilles JP, Amarenco P. Outcomes after thrombolysis in AIS according to prior statin use: a registry and review. Neurology. 2012;79:1817-1823.
10. Rubiera M, Ribo M, Pagola J, Coscojuela P, Rodriguez-Luna D, Maisterra O, Ibarra B, Piñeiro S, Meler P, Romero FJ, Alvarez-Sabin J, Molina CA. Bridging intravenous-intra-arterial rescue strategy increases recanaliza-tion and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study. Stroke. 2011;42:993-997.
11. Hassan AE, Chaudhry SA, Miley JT, Khatri R, Hassan SA, Suri MF, Qureshi AI. Microcatheter to recanalization (procedure time) predicts outcomes in endovascular treatment in patients with acute ischemic stroke: when do we stop? AJNR Am J Neuroradiol. 2013;34:354-359.
12. Roubec M, Kuliha M, Procházka V, Krajca J, Czerny D, Jonszta T, Krajina A, Sanák D, Langová K, Herzig R, Skoloudík D. A controlled trial of revascularization in acute stroke. Radiology. 2013;266:871-878.
13. Mathews MS, Sharma J, Snyder KV, Natarajan SK, Siddiqui AH, Hopkins LN, Levy EI. Safety, effectiveness, and practicality of endovascular therapy within the frst 3 hours of acute ischemic stroke onset. Neurosurgery. 2009;65:860-865.
14. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I fndings: TIMI Study Group. N Engl J Med. 1985;312:932-936.
15. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH. Intravenous thromboly-sis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
16. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352:1245-1251.
17. van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med. 2002;21:589-624.
18. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.
19. Saver JL. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke. Arch Neurol. 2004;61:1066-1070.
20. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, Saqqur M, Demchuk AM, Moyé LA, Hill MD, Wojner AW; CLOTBUST Investigators. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004;351:2170-2178.
21. Molina CA, Saver JL. Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies. Stroke. 2005;36:2311-2320.
22. Rouchaud A, Mazighi M, Labreuche J, Meseguer E, Serfaty JM, Laissy JP, Lavallée PC, Cabrejo L, Guidoux C, Lapergue B, Klein IF, Olivot JM, Abboud H, Simon O, Schouman-Claeys E, Amarenco P. Outcomes of mechanical endovascular therapy for acute ischemic stroke: a clinical registry study and systematic review. Stroke. 2011;42:1289-1294.